# EXhaled Hydrogen Peroxide As a Marker of Lung Disease Study - Conformité Européenne (European Conformity)

> **NCT04531449** · — · COMPLETED · sponsor: **Portsmouth Hospitals NHS Trust** · enrollment: 27 (actual)

## Conditions studied

- Point of Care Monitoring

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04531449
- **Lead sponsor:** Portsmouth Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-06
- **Primary completion:** 2019-10-09
- **Final completion:** 2019-10-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531449, "EXhaled Hydrogen Peroxide As a Marker of Lung Disease Study - Conformité Européenne (European Conformity)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04531449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*